Guardion Health Sciences GAAP EPS of $0.12, revenue of $12.25MSeekingAlpha.com: All News • 25 days ago
Guardion Health Sciences GAAP EPS of $0.12, revenue of $12.25M...
Share to Feed
Viactiv Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022...
Argos Therapeutics (OTCMKTS:ARGSQ Get Free Report) and Guardion Health Sciences (NASDAQ:GHSI Get Free Report) are both small-cap medical companies, but which is the superior...
Propanc Biopharma (OTCMKTS:PPCB Get Free Report) and Guardion Health Sciences (NASDAQ:GHSI Get Free Report) are both small-cap medical companies, but which is the better stock? We...
Guardion Health Sciences (NASDAQ:GHSI Get Free Report) and Amarin (NASDAQ:AMRN Get Free Report) are both small-cap medical companies, but which is the better business? We will...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ( Guardion or the Company ) announced today that it has signed an equity purchase agreement to sell...